ScholarWorks@Hanyang University: Yun, Chae Ok

Detailed Information

Yun, Chae Ok (윤채옥)

COLLEGE OF ENGINEERING (DEPARTMENT OF BIOENGINEERING)

Research Area

Tel 02-2220-0491
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Oncolytic adenovirus:20||adenovirus:16||Adenovirus:15||Cancer gene therapy:14||oncolytic adenovirus:14||Gene therapy:10||immunotherapy:7||Systemic administration:6||Relaxin:6||keloid:6||Bioreducible polymer:5||IL12:5||apoptosis:5||gene therapy:5||Active targeting:5||Pancreatic cancer:4||immunogenic cell death:3||decorin:3||angiogenesis:3||GMCSF:3||cancer therapy:3||Oncolytic virus:3||oncolytic virotherapy:3||Extracellular matrix:3||Oncolytic virotherapy:3||Hepatocellular carcinoma:3||relaxin:3||systemic administration:3||cancer:3||RGD:2||VEGF:2||RGD peptide:2||scar:2||combination cancer immunotherapy:2||DKK2:2||shRNA:2||Cationic polymer:2||cytokines:2||sustained release:2||Decorin:2||Hybrid vector:2||systemic delivery:2||alginate gel:2||mathematical model:2||Sustained release:2||MMP:2||transforming growth factor beta:2||Cationic polymers:2||metformin:2||Mathematical modelling:2||Mesenchymal stem cell:2||TGFbeta:2||PLGA:2||mortalin:2||nanocomplex:2||EGFR:2||fibrosis:2||Dendrimer:2||nanoparticles:2||cMet:2||oncolytic virus:2||cancer gene therapy:2||cancer immunogene therapy:2||Mitochondrial membrane destabilization:2||ordinary differential equations model:2||p53:2||head and neck cancer:2||pHsensitive:2||pHsensitive polymers:2||ER stress:2||pancreatic cancer:2||human dermal fibroblast:2||hydrogel:2||cationic polymers:2||polymer:2||immune checkpoint blockade:2||Tumor microenvironment:2||Chitosan:2||Polymer:2||chemotherapy:2||Argininegrafted bioreducible polymer:2||Cancer:2||costimulatory molecules:2||Proapoptotic activity:2||Hypoxia:1||Hypoxiainducible factor1α (HIF1α):1||IL18:1||In vitro:1||Infarctrelated coronary artery:1||Inorganic nanoparticles:1||Integrodifferential equation:1||Interleukin12:1||Intratumoral injection:1||Junction opener:1||Keloids:1||Liver cirrhosis:1||Liver regeneration:1||Local administration:1||Localized surface plasmon resonance:1||Lowdose immunosuppressant:1||Lung carcinoma cells:1||MDM2:1||MS275:1||Magnetofection:1||Mathematical biology:1||Melanogenesis:1||Mesenchymal stromal cell:1||Metastasis:1||Myocardial infarction:1||Nano material:1||Nanocomplex:1||Nanocomposite:1||Nanoislands:1||Nanomaterial:1||Nanomedicine:1||Neurotensin:1||Nonviral gene therapy:1||ODEs:1||Oncolytic Ad/polymer hybrid vector:1||Oncolytic adenovirusInterleukin 12Granulocytemacrophage colonystimulating factorRadiationApoptosis:1||Oncolytic adenoviruses:1||Optimisation:1||Ordinary differential equations:1||Orthotopic lung tumor model:1||PAMAM:1||PDEs:1||PEGylated and crosslinked iron oxide nanoparticles (PCION):1||PEGylation:1||PEI1.8k:1||PNLG:1||Paclitaxel:1||Pancreatic islet:1||Passive targeting:1||Perivascular coverage:1||Poly(ethylene glycol):1||Poly(ethyleneimine):1||Polyethylene glycol:1||Polyplexes:1||Porous microparticle:1||Postinfarct remodeling:1||RGDincorporated adenovirus:1||Radiotherapy:1||Regulation:1||Relaxin gene therapy:1||Rigorous coupledwave analysis:1||S100A2 promoter:1||SBHA:1||Skin Flap:1||Small hairpin RNA (shRNA):1||Syrian hamster model:1||Systemic adenovirus delivery:1||Systemic delivery:1||Systemic delivery of Ad:1||T cells expressing IL12R beta 2 or IL18R alpha:1||TEG:1||TEGderivatives:1||TTAC0001:1||Targetfield overlap:1||Targeted delivery:1||Transfer matrix method:1||Transforming growth factorbeta:1||Treg:1||Tumor angiogenesis:1||Tumor cell invasion:1||Tumor cell proliferation:1||Tumor microenvironment targeting:1||Tumor necrosis factorrelated apoptosisinducing ligand (TRAIL):1||Tumor stroma:1||Tumorassociated macrophages:1||Tumour:1||UV:1||Upregulation:1||VEGFR2(KDR):1||VSVG:1||Vessel normalization:1||Viral vectors:1||Wear:1||Wnt 3a:1||active targeting:1||adenoassociated virus:1||adoptive cell therapy:1||allogeneic natural killer cells:1||alphahelical polypeptide:1||angiogenesis inhibitors: endogenous and synthetic:1||animal models of cancer:1||anionic clay:1||antiVEGFR2 monoclonal antibody:1||antiaging:1||antitumor effect:1||antitumor effect:1||antitumor immunotherapy:1||apolipoprotein AI:1||atomic force microscopy:1||autophagic cell death:1||autophagy:1||biodistribution:1||bioreducible polymers:1||cancer immunology:1||cancer immunotherapeutics:1||cancer metastasis:1||cancerspecific promoter:1||cell death:1||cell migration:1||cervical cancer:1||chemophotothermal treatment:1||chimeric fiber:1||chirality:1||clinical research:1||collagen:1||collagens:1||colloidal stability:1||combination:1||combination therapy 4:1||conditionally replicative adenovirus:1||cross species reactivity:1||curcumin:1||data fitting:1||decorinexpressing adenovirus:1||decoy Wnt receptor:1||dendritic cell maturation:1||dendritic cells:1||desmoplasia:1||dimethoxycurcumin:1||drug delivery:1||drug delivery systems:1||elastase:1||endocytosis:1||endothelialtomesenchymal transition:1||enhanced delivery:1||enhanced permeability and retention effect:1||epidermal growth factor receptor signaling:1||epithelialmesenchymal transition:1||external stimuliinduced targeting:1||extracellular matrix:1||ferroptosis hybrid pathway:1||fiber:1||fiber modification:1||fibrogenesis:1||folate:1||gene delivery:1||genetic algorithm:1||genome editing:1||glioblastoma:1||glycyrrhizinic acid:1||gold nanorods:1||hNoxin:1||hepatocellular carcinoma:1||hydrogels:1||hyperthermia:1||hypoxia:1||hypoxia inducible factor1 alpha:1||immune checkpoint inhibitor:1||immune checkpoint inhibitor 2:1||immunooncology 3:1||inflammation:1||inhibitor:1||inorganic nanovectors:1||integrin:1||integrins:1||interleukin1 alpha receptor:1||interleukin12:1||interleukin8:1||intranasal:1||invasion:1||islets:1||keloid spheroid:1||layered compounds:1||layered double hydroxide:1||lentivirus:1||liver cirrhosis:1||liver fibrinolysis:1||liver fibrosis:1||local delivery:1||local therapy:1||lung cancer:1||lymphocytes:1||lysyl oxidase homolog:1||malignant breast cancer cells:1||matrix metalloproteinases:1||mechanisms:1||melanoma:1||mesenchymal stromal cells:1||metastasis:1||metastatic cancer:1||metastatic tumors:1||methotrexate:1||minor capsid protein:1||mitochondrial apoptosis:1||mitochondrial membrane destabilization:1||mitotic catastrophe:1||modified adenovirus (Adk35):1||mtHsp70/mortalin:1||nanomaterial:1||nanomedicine:1||nonsmallcell lung carcinoma:1||nonimmunogenic polymer:1||nonviral vectors:1||oncolytic Ad:1||oncolytic virus 1:1||oncolytic viruses:1||optimal control:1||outofframe:1||pHactivated helical formation:1||paclitaxel:1||paraptosis:1||passive targeting:1||perturbed potassium homeostasis:1||pig model:1||pig scar model:1||poly(ethylene glycol):1||polymeric delivery:1||polymeric system:1||potassium ion efflux:1||potassium ionophore:1||proteasomal inhibition:1||proteoliposome:1||radiation:1||radioimmunotherapy:1||radiotherapy:1||reconstituted highdensity lipoproteins:1||regenerative medicine:1||regulatory T cells:1||revascularization:1||s disease:1||sLRP6E1E2:1||scar remodeling:1||selfassembly:1||shRNA screening:1||short hairpin RNA (shRNA):1||siRNA delivery:1||silkelastinlike protein polymers:1||skin flap:1||stress pathways:1||supraparticles:1||sustainedrelease therapy:1||systemic antitumor immunity:1||target:1||targeting moiety:1||targeting strategies:1||telomerase:1||telomere:1||telomere dysfunction:1||therapeutic efficacy:1||therapy:1||thymic atrophy:1||transforming growth factorbeta activation:1||triethylene glycol derivatives:1||tumor microenvironment:1||tumor microenvironmentresponsive delivery:1||tumorinfiltrating:1||tumortargeted delivery:1||tumour xenograft:1||vascular endothelial growth factor:1||vasculogenesis:1||vector systems:1||viral therapy:1||viral vectors:1||ATM/ATR:1||zebrafish:1||Ad conjugated bioreducible polymer:1||Ad genome lipoplex:1||Adenoviral replication:1||Alginate:1||Angiogenesis:1||Anticancer polypeptide:1||Antitumoral effect:1||Antitumor immune response:1||Antiviral immune response:1||Ashwagandha:1||Bcellbased vaccine:1||Bifurcation theory:1||Biocompatibility:1||Biodegradable polymer:1||Biomaterials:1||Bioreducible polymers:1||Breast cancer:1||CAR dependency:1||CAR receptor:1||CART cell:1||CRISPR:1||Calcium ion delivery:1||Cancer immunogene therapy:1||Cancer targeting and therapy:1||Cardiac dysfunction:1||Cardiac extracellular matrix (ECM):1||Cas12a:1||Cell therapy:1||Cetuximab:1||Chemical conjugation:1||Chemosensitivity:1||Cicatrix:1||Clathrin:1||Clinical trials:1||Combination therapy:1||Controlled release:1||Corrosion:1||Coxsackie and adenovirus receptor:1||Cpf1:1||DAMP release:1||DC vaccination:1||DKK1:1||DNA damage:1||Del1 (Developmental Endothelial Locus1):1||Del1 (developmental endothelial locus1):1||Delivery systems:1||Deoxycholic acid:1||Diabetes:1||Doxorubicin:1||Dual gene virotherapy:1||Dupuytren&apos:1||Dynamic contrast enhanced magnetic resonance:1||Dynamin:1||Dysplastic nodule:1||E1B 19:1||E1B 55:1||ECM enhancer:1||EMT reversal:1||Efficacy:1||Electrospraying:1||Electrostatic interaction:1||Encapsulation:1||Epithelial junctions:1||Erbitux:1||Folate:1||GHPA gel:1||GM101:1||Gelatin hydrogel:1||Gemcitabine:1||Gene Therapy:1||Gene delivery:1||Graphene:1||HMGB1:1||Heine oxygenase1:1||Hepatocarcinogenesis:1||Hepatocyte Growth Factor:1||Hepatoma cancer targeting peptide:1||Histone deacetylase inhibitor:1||Hsp60:1||Human stem cell:1||Human umbilical vein endothelial cells (HUVECs):1||Hydrogels:1||Hydroxyapatite:1||

STATISTICS: Total View :4,990,373; Today View :11,459

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE